You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial
|
|---|---|
| Published in |
Lancet Oncology, July 2015
|
| DOI | 10.1016/s1470-2045(15)00187-4 |
| Pubmed ID | |
| Authors |
Michael A Henderson, Bryan H Burmeister, Jill Ainslie, Richard Fisher, Juliana Di Iulio, B Mark Smithers, Angela Hong, Kerwin Shannon, Richard A Scolyer, Scott Carruthers, Brendon J Coventry, Scott Babington, Joao Duprat, Harald J Hoekstra, John F Thompson |
X Demographics
The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 12% |
| Mexico | 2 | 12% |
| Spain | 2 | 12% |
| Costa Rica | 1 | 6% |
| New Zealand | 1 | 6% |
| Italy | 1 | 6% |
| Netherlands | 1 | 6% |
| Unknown | 7 | 41% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 71% |
| Practitioners (doctors, other healthcare professionals) | 4 | 24% |
| Scientists | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 241 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | <1% |
| Netherlands | 1 | <1% |
| Ecuador | 1 | <1% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 235 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 36 | 15% |
| Other | 33 | 14% |
| Student > Postgraduate | 24 | 10% |
| Student > Master | 24 | 10% |
| Student > Ph. D. Student | 23 | 10% |
| Other | 48 | 20% |
| Unknown | 53 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 141 | 59% |
| Agricultural and Biological Sciences | 6 | 2% |
| Biochemistry, Genetics and Molecular Biology | 6 | 2% |
| Nursing and Health Professions | 4 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 2% |
| Other | 11 | 5% |
| Unknown | 69 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#1,990,766
of 25,837,817 outputs
Outputs from Lancet Oncology
#2,045
of 6,943 outputs
Outputs of similar age
#24,604
of 277,348 outputs
Outputs of similar age from Lancet Oncology
#35
of 154 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,943 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.3. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,348 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 154 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.